Esketamine induces embryonic and cardiac malformation through regulating the nkx2.5 and gata4 in zebrafish
Abstract Esketamine (EK) has been widely used in the treatment of depression, but the effects of EK prenatal treatment on embryonic heart development have been rarely reported. This study assesses the effects of varying concentrations of EK on embryonic development and cardiogenesis to determine the...
Saved in:
| Main Authors: | Shuang Li, Xiang Li, Rui Zhao, Tingyu Jiang, Qiuyun Ou, Huansen Huang, Jiancheng Tang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-02-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-025-91315-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expression of sumoylation deficient Nkx2.5 mutant in Nkx2.5 haploinsufficient mice leads to congenital heart defects.
by: Eun Young Kim, et al.
Published: (2011-01-01) -
Non‐invasive lung cancer diagnosis by detection of GATA6 and NKX2‐1 isoforms in exhaled breath condensate
by: Aditi Mehta, et al.
Published: (2016-11-01) -
Complex SUMO-1 regulation of cardiac transcription factor Nkx2-5.
by: Mauro W Costa, et al.
Published: (2011-01-01) -
Bioenergetic profiling of zebrafish embryonic development.
by: Krista D Stackley, et al.
Published: (2011-01-01) -
The impact of esketamine on cardiac function in patients undergoing anesthesia
by: Edward Sun, et al.
Published: (2025-03-01)